Clinical Trials Browser

Phase 3 × Neoplasms, Plasma Cell × Diphosphonates × Clear all

NCT00222053 2010-04-02

IFM 99-02 Thalidomide in Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell